The All-Russian Infectious Diseases Congress is of great social, research and practice significance. It grants opportunity for leading infectious disease specialists to discuss key issues on ensuring biosafety of our country’s population, present-day development in the field of causative microorganisms, pathogenesis, diagnostics, treatment, and prevention of infectious diseases including influenza, one of the current healthcare issues due to high incidence and complications risk.
At the Forum, JSC Pharmasyntez introduced a high quality antiviral drug, which is a generic of the costly import brand-name drug. This drug is indicated for influenza prevention and treatment in adults and children aged of 3 years and over and reduces significantly the infection symptoms and complications incidence. This Russian affordable drug competes already with the import ones at the pharmaceutical market. The drug is produced in capsules and tablets of various strength, including pediatric safe dosages, which is unique for the Russian market.
The All-Russian Infectious Diseases Congress is organized annually. Theoretical issues are also in focus of the event: immunological aspects of infection process, pathogenesis of disease and its complications, advanced diagnostics and treatment approaches and, most importantly, infection prophylaxis in adults and children.